• Multivitamin for infusion (MVI) Adult, Pfizer
  MVI Adult, 10 mL two-chambered vial, 10 count (NDC 61703-0422-81) - discontinued
  MVI Adult, 2 x 5 mL Dual vial, 10 count (NDC 61703-0422-82)

• • Pfizer states the shortage is due to manufacturing delays.
  • Baxter has all presentations fully available at this time.

• Infuvite injection, Baxter
  Adult, 2 x 5 mL single dose vial, 100 count (NDC 54643-5649-01)

Estimated Resupply Dates

• • Pfizer has M.V.I. adult 5 mL and 50 mL Dual vials on back order and the company estimates a release date of August 2017 for the 5 mL vials and mid-July 2017 for the 50 mL vials.
  • Pfizer has M.V.I. pediatric 5 mL vials on back order and the company estimates a release date of December 2017.
    

Alternative Agents & Management

• • The American Society for Parenteral and Enteral Nutrition (ASPEN) has detailed recommendations for managing an intravenous multivitamin shortage in adults and pediatric patients online.
  • Key recommendations include:
    • Use oral or enteral multivitamin preparations whenever possible.
    • Use of pediatric intravenous multivitamins for adults is not recommended and may result in a shortage of pediatric products.
    • Use of multivitamin preparations without vitamin K is fine with individual supplementation of Vitamin K products. Ensure patients receiving vitamin K are getting adequate anticoagulation if they are on warfarin.
    • Reserve intravenous multivitamins for patients receiving parenteral nutrition.
    • Reserve pediatric intravenous multivitamins for children less than 2.5 kg or less than 36 weeks gestational age.
    • When all supply options are exhausted, ration intravenous multivitamins in parenteral nutrition or administer individual parenteral vitamins.
    • Purchase only the supply needed, do not stockpile.